Related content

A novel series of potent and selective IKK2 inhibitors

By Bingham A.H.   Davenport R.J.   Gowers L.   Knight R.L.   Lowe C.   Owen D.A.   Parry D.M.   Pitt W.R.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 409-412

Elsevier

Access to resources Recommend Favorite

A quantitative structure-activity relationship study of novel, potent, orally active, selective VEGFR-2 and PDGFRα tyrosine kinase inhibitors: Derivatives of N-Phenyl-N'-{4-(4-quinolyloxy)phenyl}urea as antitumor agents

By Sharma B. K.   Sharma S. K.   Singh P.   Sharma Susheela  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 23, Iss. 2, 2007-06 ,pp. : 168-173

Informa Healthcare

Access to resources Recommend Favorite

A new series of potent oxindole inhibitors of CDK2

By Luk K.-C.   Simcox M.E.   Schutt A.   Rowan K.   Thompson T.   Chen Y.   Kammlott U.   DePinto W.   Dunten P.   Dermatakis A.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 4, 2004-02 ,pp. : 913-917

Elsevier

Access to resources Recommend Favorite

ABCG2: recent discovery of potent and highly selective inhibitors

By Lecerf-Schmidt Florine   Peres Basile   Valdameri Glaucio   Gauthier Charlotte   Winter Evelyn   Payen Léa   Di Pietro Attilio   Boumendjel Ahcène  

Future Medicinal Chemistry, Vol. 5, Iss. 9, 2013-06 ,pp. : 1037-1045

Future Science

Access to resources Recommend Favorite

Synthesis of potent and selective 2-azepanone inhibitors of human tryptase

By Zhao G.   Bolton S.A.   Kwon C.   Hartl K.S.   Seiler S.M.   Slusarchyk W.A.   Sutton J.C.   Bisacchi G.S.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 309-312

Elsevier

Access to resources Recommend Favorite